Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co (CHGCF)
:CHGCF
RESEARCH TOOLSreports
Total Valuation
Chugai Pharmaceutical Co has a market cap or net worth of $73.79B. The enterprise value is $11.37T.
Market Cap$73.79B
Enterprise Value$11.37T
Share Statistics
Chugai Pharmaceutical Co has 1,679,057,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,679,057,600
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Chugai Pharmaceutical Co’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 20.16%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)20.16%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee232.91M
Profits Per Employee77.06M
Employee Count5,026
Asset Turnover0.53
Inventory Turnover1.42
Valuation Ratios
The current PE Ratio of Chugai Pharmaceutical Co is 29.3. Chugai Pharmaceutical Co’s PEG ratio is ―.
PE Ratio29.3
PS Ratio―
PB Ratio―
Price to Fair Value6.06
Price to FCF―
Price to Operating Cash Flow23.08
PEG Ratio―
Income Statement
In the last 12 months, Chugai Pharmaceutical Co had revenue of 1.17T and earned 387.32B in profits. Earnings per share was 235.39.
Revenue1.17T
Gross Profit830.75B
Operating Income543.91B
Pretax Income543.03B
Net Income387.32B
EBITDA574.80B
Earnings Per Share (EPS)235.39
Cash Flow
In the last 12 months, operating cash flow was 464.10B and capital expenditures -66.77B, giving a free cash flow of 397.33B billion.
Operating Cash Flow464.10B
Free Cash Flow397.33B
Free Cash Flow per Share236.64
Dividends & Yields
Chugai Pharmaceutical Co pays an annual dividend of $0.811, resulting in a dividend yield of 3.38%
Dividend Per Share$0.811
Dividend Yield3.38%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change5.42%
50-Day Moving Average46.03
200-Day Moving Average46.33
Relative Strength Index (RSI)55.62
Average Volume (3m)2.85K
Important Dates
Chugai Pharmaceutical Co upcoming earnings date is Oct 24, 2025, Before Open (Confirmed).
Last Earnings DateJul 24, 2025
Next Earnings DateOct 24, 2025
Ex-Dividend DateDec 31, 2025
Financial Position
Chugai Pharmaceutical Co as a current ratio of 5.53, with Debt / Equity ratio of 0.67%
Current Ratio5.53
Quick Ratio4.70
Debt to Market Cap<0.01
Net Debt to EBITDA-0.92
Interest Coverage Ratio5.73K
Taxes
In the past 12 months, Chugai Pharmaceutical Co has paid 155.72B in taxes.
Income Tax155.72B
Effective Tax Rate0.29
Enterprise Valuation
Chugai Pharmaceutical Co EV to EBITDA ratio is 19.12, with an EV/FCF ratio of 27.70.
EV to Sales9.39
EV to EBITDA19.12
EV to Free Cash Flow27.70
EV to Operating Cash Flow24.55
Balance Sheet
Chugai Pharmaceutical Co has $1.03T in cash and marketable securities with $13.20B in debt, giving a net cash position of -$1.01T billion.
Cash & Marketable Securities$1.03T
Total Debt$13.20B
Net Cash-$1.01T
Net Cash Per Share-$604.15
Tangible Book Value Per Share$1.14K
Margins
Gross margin is 70.37%, with operating margin of 46.46%, and net profit margin of 33.09%.
Gross Margin70.37%
Operating Margin46.46%
Pretax Margin46.39%
Net Profit Margin33.09%
EBITDA Margin49.10%
EBIT Margin46.40%
Analyst Forecast
The average price target for Chugai Pharmaceutical Co is $55.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$55.40
Price Target Upside17.72% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―